Keywordsmicrospheres; poly(lactide-co-glycolide); nanohydroxyapatite; scaffold; tissue engineering; osteochondral; biphasic; anastomosis; drug delivery; microneedle; restenosis; peripheral vascular disease; polymer; polyethylene terephthalate (PET); SO2 plasma treatment; surface modification; wettability; X-ray photoelectron spectroscopy (XPS); atomic force microscopy (AFM); human umbilical endothelial cell (HUVEC) proliferation; MTT; toxicity; scanning electron microscopy (SEM); artificial spores; cell-surface engineering; immunoprotection; nanocoating; red blood cells; supramolecular complex; poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV); calcium silicate; composite scaffolds; bioactivity; mechanical properties; cytocompatibility; radiopaque polymer; 3D printed bone screw; iron oxide nanoparticles; poly-l-lactic acid; thermogelling; diblock copolymer; pendant group; crystallinity; phase transition; porous microspheres (PMSs); biphasic calcium phosphate (BCP); MG-63 cells; osteogenic activity; 3D cellular assembly; optical tweezers; crowding effect; depletion effect; remote control; mechanical property; cell behavior; small diameter vascular graft; fibrin glue; rolling; poly(ε-caprolactone); electrospinning; scaffolds; three-dimensional cell culture; triple negative breast cancer; breast cancer stem cells; mammospheres; aldehyde dehydrogenase; cell aggregate; hydrogel; poly (lactide-co-caprolactone); cartilage regeneration; hanging drop method; dextran; catechol conjugation; surface coating; antiplatelet; cell scaffolds; atomic force microscopy; 3D bioprinting; gelatin-based hydrogels; rapid prototyping (RP); organ manufacturing; implantable bioartificial organs; guided bone regeneration; hydroxyapatite; PLGA; oxygen plasma treatment; magnetron sputtering; adipose-derived stem cells; bone marrow stem cells; osteogenesis; 3D-printed scaffold; polycaprolactone; tricalcium phosphate; dog; maxillary bone; electrospinning; benign solvents; mesoporous silica calcium containing MCM-41; composites; nanofibers; poly(epsilon-caprolactone); n/a; cytoskeleton architecture; stem cell fate; regenerative medicine
